Stephanie Schwartz

ORCID: 0009-0009-0388-0887
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Alzheimer's disease research and treatments
  • Pneumonia and Respiratory Infections
  • Inflammasome and immune disorders
  • Bacterial Infections and Vaccines
  • Respiratory viral infections research
  • Immune cells in cancer
  • Tryptophan and brain disorders
  • Microbial infections and disease research
  • Galectins and Cancer Biology
  • S100 Proteins and Annexins
  • Immune Response and Inflammation
  • Peptidase Inhibition and Analysis
  • Macrophage Migration Inhibitory Factor
  • Neuroscience and Neuropharmacology Research
  • Autoimmune and Inflammatory Disorders Research
  • Amoebic Infections and Treatments
  • Peroxisome Proliferator-Activated Receptors
  • Neurogenetic and Muscular Disorders Research
  • Cancer Cells and Metastasis
  • Poxvirus research and outbreaks
  • Nicotinic Acetylcholine Receptors Study
  • Chronic Lymphocytic Leukemia Research
  • Protein Tyrosine Phosphatases
  • Cancer survivorship and care

University Hospital Bonn
2019-2025

University of Bonn
2005-2023

German Center for Neurodegenerative Diseases
2019-2022

Centers for Disease Control and Prevention
2002-2021

National Center for Immunization and Respiratory Diseases
2016-2021

Novartis (United States)
2020

Centre de Recherche Médicale et Sanitaire
2016

Agence de Médecine Préventive
2016

World Health Organization
2016

Institut Pasteur
2016

Abstract Despite the increasing interest in targeting stromal elements of tumor microenvironment, we still face tremendous challenges developing adequate therapeutics to modify landscape. A major obstacle this is our poor understanding phenotypic and functional heterogeneity cells tumors. Herein, perform an unbiased interrogation mesenchymal cells, delineating co-existence distinct subsets cancer-associated fibroblasts (CAFs) microenvironment murine carcinomas, each endowed with unique...

10.1038/s41467-020-19920-5 article EN cc-by Nature Communications 2020-12-09

Microglia are crucial for maintaining brain health and neuron function. Here, we report that microglia establish connections with neurons using tunneling nanotubes (TNTs) in both physiological pathological conditions. These TNTs facilitate the rapid exchange of organelles, vesicles, proteins. In neurodegenerative diseases like Parkinson's Alzheimer's disease, toxic aggregates alpha-synuclein (α-syn) tau accumulate within neurons. Our research demonstrates use to extract from these...

10.1016/j.neuron.2024.06.029 article EN cc-by Neuron 2024-07-25

Abstract The bioterrorism-associated human anthrax epidemic in the fall of 2001 highlighted need for a sensitive, reproducible, and specific laboratory test confirmatory diagnosis anthrax. Centers Disease Control Prevention developed, optimized, rapidly qualified an enzyme-linked immunosorbent assay (ELISA) immunoglobulin G (IgG) antibodies to Bacillus anthracis protective antigen (PA) serum. ELISA had minimum detection limit 0.06 µg/mL, reliable lower 0.09 quantification undiluted serum...

10.3201/eid0810.020380 article EN cc-by Emerging infectious diseases 2002-10-01

Mycoplasma pneumoniae is a significant cause of community-acquired pneumonia, which often empirically treated with macrolides or azalides such as erythromycin azithromycin. Recent studies have discovered the existence macrolide-resistant strains within population that been mapped to mutations domain V region 23S rRNA gene. Currently, identification these resistant relies on time-consuming and labor-intensive procedures restriction fragment length polymorphism, MIC studies, sequence analysis....

10.1128/aac.00582-08 article EN Antimicrobial Agents and Chemotherapy 2008-07-22

Abstract Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder causing memory loss, language problems and behavioural disturbances. AD associated with accumulation of fibrillar amyloid‐β (Aβ) formation neurofibrillary tau tangles. Fibrillar Aβ itself represents a danger‐associated molecular pattern, which recognized by specific microglial receptors. One key players NOD‐, LRR‐ pyrin domain‐containing 3 (NLRP3) inflammasome, whose activation has been demonstrated in patient...

10.1111/jnc.14945 article EN cc-by Journal of Neurochemistry 2019-12-24

Article26 November 2021Open Access Transparent process Microglial PD-1 stimulation by astrocytic PD-L1 suppresses neuroinflammation and Alzheimer's disease pathology Markus P Kummer Corresponding Author [email protected] orcid.org/0000-0002-0993-2918 Department of Neurodegenerative Diseases Geriatric Psychiatry, University Bonn Medical Faculty, Bonn, Germany These authors contributed equally to this work Search for more papers author Christina Ising orcid.org/0000-0002-7267-3488 German...

10.15252/embj.2021108662 article EN cc-by-nc-nd The EMBO Journal 2021-11-26

Abstract SHP2 is a ubiquitous tyrosine phosphatase involved in regulating both tumor and immune cell signaling. In this study, we discovered novel modulatory function of SHP2. Targeting protein with allosteric inhibitors promoted anti-tumor immunity, including enhancing T cytotoxic immune-mediated regression. Knockout using CRISPR/Cas9 gene editing showed that targeting cancer cells contributes to response. Inhibition activity augmented intrinsic IFNγ signaling resulting enhanced...

10.1038/s41598-021-80999-x article EN cc-by Scientific Reports 2021-01-14

Neuroinflammation is a common feature of many neurodegenerative diseases. It fosters dysfunctional neuron-microglia-astrocyte crosstalk that, in turn, maintains microglial cells perniciously reactive state that often enhances neuronal damage. The molecular components mediate this critical communication are not fully explored. Here, we show secreted frizzled-related protein 1 (SFRP1), multifunctional regulator cell-to-cell communication, part the cellular underlying neuroinflammation. In...

10.15252/embr.202051696 article EN cc-by-nc-nd EMBO Reports 2021-09-27

Sabatolimab is a humanized monoclonal antibody (hIgG4, S228P) directed against human T-cell immunoglobulin domain and mucin domain-3 (TIM-3). Herein, we describe the development characterization of sabatolimab.Sabatolimab was tested for binding to its target TIM-3 blocking properties. The functional effects sabatolimab were in killing myeloid cell cytokine assays. Antibody-mediated phagocytosis (ADCP) by also assessed.Sabatolimab shown (i) enhance inflammatory production dendritic cells...

10.1093/immadv/ltac019 article EN cc-by Immunotherapy Advances 2022-01-01

The highest risk factor for the development of neurodegenerative diseases like tauopathies is aging. Many physiological decrements underlying aging are linked to cellular senescence. Senescent cells characterized by an irreversible growth arrest and formation a senescence-associated secretory phenotype (SASP), proinflammatory secretome that modifies microenvironment contributes tissue deterioration. Microglia, innate immune in brain, can enter senescent state during In addition, microglia...

10.1111/jnc.15866 article EN cc-by-nc-nd Journal of Neurochemistry 2023-06-05

To assess the consequences of locus ceruleus (LC) degeneration and subsequent noradrenaline (NA) deficiency in early Alzheimer's disease (AD), mice overexpressing mutant amyloid precursor protein presenilin-1 (APP/PS1) were crossed with Ear2(-/-) that have a severe loss LC neurons projecting to hippocampus neocortex. Testing spatial memory hippocampal long-term potentiation revealed an impairment APP/PS1 mice, whereas or showed only minor changes. These deficits associated distinct synaptic...

10.1523/jneurosci.4027-13.2014 article EN Journal of Neuroscience 2014-06-25

In 2015, Niger reported the largest epidemic of Neisseria meningitidis serogroup C (NmC) meningitis in sub-Saharan Africa. The NmC coincided with W (NmW) cases during season, resulting a total 9,367 meningococcal through June 2015. To clarify phylogenetic association, genetic evolution, and antibiotic determinants strains Niger, we sequenced genomes 102 isolates from this epidemic, comprising 81 21 NmW isolates. 82 were completed, all included analysis. All had sequence type 10217, which...

10.3201/eid2210.160468 article EN cc-by Emerging infectious diseases 2016-08-25

Mycoplasma pneumoniae is an important etiologic agent of primary atypical pneumonia in children and adults. The diagnosis M. infection commonly confirmed through serologic testing. In this study, we used paired sera from 51 patients (all with positive complement fixation [CF] titers) to compare the results eight enzyme immunoassays (EIAs) available commercially United States. We compared two single-use EIAs six plate-type EIAs. Results acute-phase ranged only 7 (14%) by ImmunoWELL (GenBio)...

10.1128/cdli.11.5.862-867.2004 article EN Clinical and Vaccine Immunology 2004-09-01

Alzheimer's disease (AD) is a neurodegenerative condition that leads to neuronal death and memory dysfunction. In the past, specific peroxisome proliferator-activated receptor (PPAR)γ-agonists, such as pioglitazone, have been tested with limited success improve AD pathology. Here, we investigated therapeutic efficacy of GFT1803, novel potent PPAR agonist activates all three isoforms (α/δ/γ) in APP/PS1 mouse model comparison selective PPARγ-agonist pioglitazone. Both compounds showed similar...

10.1007/s12035-014-8743-4 article EN cc-by Molecular Neurobiology 2014-05-16

Abstract Increasing evidence suggests that both synaptic loss and neuroinflammation constitute early pathologic hallmarks of Alzheimer’s disease. A downstream event during inflammatory activation microglia astrocytes is the induction nitric oxide synthase type 2, resulting in an increased release post‐translational S‐nitrosylation protein cysteine residues. Both events, inflammation dysfunction, could be connected if this excess nitrosylation occurs on proteins. In long term, such changes...

10.1111/jnc.14870 article EN cc-by Journal of Neurochemistry 2019-09-14
Coming Soon ...